{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:00:10Z","timestamp":1777532410388,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the General Research Program in Medicine and Health of Zhejiang Province","award":["2023KY492"],"award-info":[{"award-number":["2023KY492"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The factors influencing the onset of new atrial fibrillation following the Morrow procedure due to cardiopulmonary bypass (CPB) are unclear. This study investigated the CPB-related factors associated with postoperative atrial fibrillation (POAF) in patients undergoing minimally invasive ventricular septal myectomy (Morrow procedure) to optimize CPB strategies, reduce the incidence of POAF, and enhance recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective clinical data analysis was conducted on 139 patients who underwent minimally invasive Morrow procedures from January to December 2023. The patients were divided into two groups based on whether they developed new-onset atrial fibrillation after surgery, and a comparative study was performed. Multivariate regression analysis were used to assess factors potentially influencing POAF during CPB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty (36%) patients developed POAF. Comparisons between the POAF group and the non-POAF group revealed significant differences in preoperative hypertension (38.0% vs. 14.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), ischaemic cardiomyopathy (40.0% vs. 20.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.012), history of heart failure (44.0% vs. 22.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008), age (55.16\u2009\u00b1\u200914.11 vs. 46.28\u2009\u00b1\u200914.55,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), the preoperative systemic immune-inflammation index (SII) (418.26\u2009\u00b1\u2009243.97 vs. 330.24\u2009\u00b1\u2009152.89,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019), the left atrial volume index (LAVI) (36.79\u2009\u00b1\u200912.08 vs. 32.24\u2009\u00b1\u200910.78,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024), CPB time (129.80\u2009\u00b1\u200939.58 vs. 116.96\u2009\u00b1\u200928.80,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.027), CPB weaning time (25.68\u2009\u00b1\u200922.56 vs. 19.49\u2009\u00b1\u20096.78,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018), rate of re-CPB (14.0% vs. 3.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020), rate of ultrafast-track cardiac anesthesia (UFTCA) (78.0% vs. 98.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.000), and \u0394SII (2874.58\u2009\u00b1\u20092865.98 vs. 1981.85\u2009\u00b1\u20091519.89,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). All patients were discharged, but the ICU (2.07\u2009\u00b1\u20092.91 vs. 1.38\u2009\u00b1\u20090.78,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.046) and postoperative hospital stays (11.84\u2009\u00b1\u20097.50 vs. 9.13\u2009\u00b1\u20092.62,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) were significantly prolonged. The results of the multivariate logistic regression analysis indicated that the occurrence of POAF was independently associated with age (OR\u2009=\u20091.047, 95% CI: 1.015\u20131.080), \u0394SII(OR\u2009=\u200913.317, 95% CI: 3.103\u201357.154) and UFTCA(OR\u2009=\u20090.054, 95% CI: 0.006\u20130.493) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Additionally, the increased value of SII was independently associated with CPB weaning time (t\u2009=\u20092.493,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014) and age(t=-2.270,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>UFTCA is a protective factor against POAF. Age and \u0394SII are risk factors for the occurrence of POAF after the Morrow procedure. CPB weaning time and Age are significant influencing factors of \u0394SII. Implementing UFTCA and shortening the CPB weaning time are expected to lower the risk of POAF, shorten ICU and hospital stays, and enhance recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-025-04514-0","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T05:57:30Z","timestamp":1738303050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of postoperative atrial fibrillation and its associated factors in Morrow procedures with cardiopulmonary bypass"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhibin","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenshuai","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xujie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"issue":"5","key":"4514_CR1","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.21037\/jtd-19-3875","volume":"12","author":"R Skaria","year":"2020","unstructured":"Skaria R, Parvaneh S, Zhou S, Kim J, Wanjiru S, Devers G, et al. Path to precision: prevention of post-operative atrial fibrillation. J Thorac Dis. 2020;12(5):2735\u201346.","journal-title":"J Thorac Dis"},{"issue":"11","key":"4514_CR2","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jamacardio.2019.3649","volume":"4","author":"JH Butt","year":"2019","unstructured":"Butt JH, Olesen JB, Gundlund A, K\u00fcmler T, Olsen PS, Havers-Borgersen E, et al. Long-term thromboembolic risk in patients with postoperative atrial Fibrillation after Left-Sided Heart Valve surgery. JAMA Cardiol. 2019;4(11):1139\u201347.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"4514_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/aas.13507","volume":"64","author":"T Gudbjartsson","year":"2020","unstructured":"Gudbjartsson T, Helgadottir S, Sigurdsson MI, Taha A, Jeppsson A, Christensen TD, et al. New-onset postoperative atrial fibrillation after heart surgery. Acta Anaesthesiol Scand. 2020;64(2):145\u201355.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"4514_CR4","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.21037\/jtd-23-1626","volume":"16","author":"OR Suero","year":"2024","unstructured":"Suero OR, Ali AK, Barron LR, Segar MW, Moon MR, Chatterjee S. Postoperative atrial fibrillation (POAF) after cardiac surgery: clinical practice review. J Thorac Dis. 2024;16(2):1503\u201320.","journal-title":"J Thorac Dis"},{"issue":"2","key":"4514_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.31083\/j.rcm2202040","volume":"22","author":"M Qureshi","year":"2021","unstructured":"Qureshi M, Ahmed A, Massie V, Marshall E, Harky A. Determinants of atrial fibrillation after cardiac surgery. Rev Cardiovasc Med. 2021;22(2):329\u201341.","journal-title":"Rev Cardiovasc Med"},{"issue":"3","key":"4514_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.112.000849","volume":"128","author":"MY Desai","year":"2013","unstructured":"Desai MY, Bhonsale A, Smedira NG, Naji P, Thamilarasan M, Lytle BW, et al. Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction. Circulation. 2013;128(3):209\u201316.","journal-title":"Circulation"},{"issue":"2","key":"4514_CR7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jtcvs.2020.01.077","volume":"162","author":"JD Matos","year":"2021","unstructured":"Matos JD, McIlvaine S, Grau-Sepulveda M, Jawitz OK, Brennan JM, Khabbaz KR, et al. Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: prescription patterns and 30-day outcomes in the United States and Canada. J Thorac Cardiovasc Surg. 2021;162(2):616\u2013e243.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"4514_CR8","first-page":"209","volume":"61","author":"Y Cui","year":"2023","unstructured":"Cui Y, Wang SW, Zhou B, Han EL, Liu ZF, Wu CH, et al. [Minimally invasive right infra-axillary thoracotomy for transaortic modified Morrow procedure: a series of 60 cases]. Zhonghua Wai Ke Za Zhi. 2023;61(3):209\u201313.","journal-title":"Zhonghua Wai Ke Za Zhi"},{"issue":"5","key":"4514_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1053\/j.jvca.2023.01.010","volume":"37","author":"S Jiang","year":"2023","unstructured":"Jiang S, Wang L, Teng H, Lou X, Wei H, Yan M. The clinical application of Ultra-fast-track Cardiac Anesthesia in Right-Thoracoscopic minimally invasive cardiac surgery: a retrospective observational study. J Cardiothorac Vasc Anesth. 2023;37(5):700\u20136.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"4514_CR10","first-page":"93","volume":"22","author":"ZB Hu","year":"2024","unstructured":"Hu ZB, Mao WS, Guo LJ, Liu ZW, Ge GX, Wang SW, et al. Clinical experience summary of modified Del Nido Cardioplegia for videoassisted right subaxillary minimally invasive cardiac surgery. Chin JECC. 2024;22(2):93\u20137.","journal-title":"Chin JECC"},{"issue":"12","key":"4514_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/eurheartj\/ehad019","volume":"44","author":"M Gaudino","year":"2023","unstructured":"Gaudino M, Di Franco A, Rong LQ, Piccini J, Mack M. Postoperative atrial fibrillation: from mechanisms to treatment. Eur Heart J. 2023;44(12):1020\u201339.","journal-title":"Eur Heart J"},{"issue":"1","key":"4514_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jtcvs.2017.07.063","volume":"155","author":"E Akintoye","year":"2018","unstructured":"Akintoye E, Sellke F, Marchioli R, Tavazzi L, Mozaffarian D. Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery. J Thorac Cardiovasc Surg. 2018;155(1):242\u2013e5110.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"4514_CR13","doi-asserted-by":"publisher","first-page":"e020426","DOI":"10.1161\/JAHA.120.020426","volume":"10","author":"D Conen","year":"2021","unstructured":"Conen D, Wang MK, Devereaux PJ, Whitlock R, McIntyre WF, Healey JS, et al. New-Onset Perioperative Atrial Fibrillation after coronary artery bypass grafting and long-term risk of adverse events: an analysis from the CORONARY Trial. J Am Heart Assoc. 2021;10(12):e020426.","journal-title":"J Am Heart Assoc"},{"key":"4514_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijcard.2022.11.016","volume":"370","author":"P Berretta","year":"2023","unstructured":"Berretta P, De Angelis V, Alfonsi J, Pierri MD, Malvindi PG, Zahedi HM, et al. Enhanced recovery after minimally invasive heart valve surgery: early and midterm outcomes. Int J Cardiol. 2023;370:98\u2013104.","journal-title":"Int J Cardiol"},{"issue":"3","key":"4514_CR15","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.jvca.2021.02.035","volume":"36","author":"G Maj","year":"2022","unstructured":"Maj G, Regesta T, Campanella A, Cavozza C, Parodi G, Audo A. Optimal management of patients treated with minimally invasive cardiac surgery in the era of enhanced recovery after surgery and fast-track protocols: a narrative review. J Cardiothorac Vasc Anesth. 2022;36(3):766\u201375.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"4514_CR16","first-page":"717","volume":"57","author":"P Berretta","year":"2020","unstructured":"Berretta P, Cefarelli M, Montecchiani L, Alfonsi J, Vessella W, Zahedi MH, et al. Minimally invasive versus standard extracorporeal circulation system in minimally invasive aortic valve surgery: a propensity score-matched study. Eur J Cardiothorac Surg. 2020;57(4):717\u201323.","journal-title":"Eur J Cardiothorac Surg"},{"key":"4514_CR17","doi-asserted-by":"publisher","first-page":"1290610","DOI":"10.3389\/fcvm.2024.1290610","volume":"11","author":"YC Chen","year":"2024","unstructured":"Chen YC, Liu CC, Hsu HC, Hung KC, Chang YJ, Ho CN, et al. Systemic immune-inflammation index for predicting postoperative atrial fibrillation following cardiac surgery: a meta-analysis. Front Cardiovasc Med. 2024;11:1290610.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"4514_CR18","first-page":"e59869","volume":"16","author":"S Mittal","year":"2024","unstructured":"Mittal S, Bhushan R, Jhajhria N, Aiyer PV, Grover V. The significance of systemic inflammatory markers in \u2018New-Onset Atrial Fibrillation\u2019 following cardiac surgeries. Cureus. 2024;16(5):e59869.","journal-title":"Cureus"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04514-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04514-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04514-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T05:57:36Z","timestamp":1738303056000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04514-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4514"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04514-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5346754\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Zhejiang Provincial People\u2019s Hospital (Approval No. Zhe Ren Yi Lun Shen 2024 Yan Di 244). All procedures during the study were consistent with the relevant guidelines of the Declaration of Helsinki. Written informed consent was exempted because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}